| Financial Year |
March 31 2023 |
| Monetary Funds |
320,774,653.62 |
| Held-for-trading Financial Assets |
632,363,686.42 |
| Notes Receivable |
125,300,277.68 |
| Accounts Receivable |
751,187,538.26 |
| Advances to Suppliers |
25,251,966.55 |
| Other Receivables |
9,671,810.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
843,472,972.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,452,758.29 |
| Total Current Assets |
2,783,826,713.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
94,623,691.69 |
| Investment Properties |
73,581,132.44 |
| Fixed Assetes |
413,867,634.60 |
| Under-construction Projects |
246,251,349.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
138,840,768.68 |
| R&D expenses |
-- |
| Goodwill |
466,654,203.22 |
| Long-Term Deferred and Prepaid Expenses |
2,658,789.43 |
| Deferred Income Tax Assets |
125,725,032.50 |
| Other Non-Current Assets |
46,868,465.79 |
| Sub-Total of Non-Current Assets |
1,634,543,719.11 |
| Total Assets |
4,418,370,432.12 |
| Short-Term Loans |
965,743,166.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
121,068,336.61 |
| Accounts Payable |
321,320,132.82 |
| Accounts Received In Advance |
8,972,611.50 |
| Employee Compensation Payable |
15,346,337.30 |
| Taxes Payable |
14,792,186.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,254,500.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
144,860,536.35 |
| Other Current Liabilities |
1,805,052.68 |
| Sub-Total of Current Liabilities |
1,620,485,937.60 |
| Long-term Loans |
256,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,894,782.40 |
| Deferred Income Tax Liabilities |
4,376,133.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
328,838,370.38 |
| Total Liabilities |
1,949,324,307.98 |
| Paid-In Capital(Or Share Stock) |
392,886,000.00 |
| Capital Surplus |
1,625,552,572.78 |
| Surplus Reserve |
44,688,618.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
390,100,871.84 |
| Minority Stockholder's Interest |
12,286,018.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,456,760,105.49 |
| Owner's Equity（Stockholder's Equity） |
2,469,046,124.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,418,370,432.12 |
